| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Raben David serves as a Chief Medical Officer at BCAX. Across recent SEC filings that breaks down to 0 buys and 8 sells. Those positions are worth an estimated $1.3M at current prices.
Historically, Raben David's trades have earned a below-average insider score of 49/100 across 5 rated trades. On a 3-month view, 60.0% of the rated trades came out ahead, averaging -4.8% over three months.
The biggest single holding is BCAX (~$1.3M) as Chief Medical Officer. The recent filings there lean toward selling, a net 60,500 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 27, 2026 | BCAX Bicara Therapeutics Inc. | Chief Medical Officer | Sale+OE10b5-1 | 5,500 | $22.88 | $125,830.10 | -9.0% | +23.7% | - | |
| Mar 25, 2026 | BCAX Bicara Therapeutics Inc. | Chief Medical Officer | Sale+OE10b5-1 | 5,500 | $18.95 | $104,229.40 | -9.0% | +33.8% | - | |
| Mar 4, 2026 | BCAX Bicara Therapeutics Inc. | Chief Medical Officer | Sale+OE10b5-1 | 16,500 | $18.52 | $305,610.01 | -23.0% | +5.9% | - | |
| Nov 25, 2025 | BCAX Bicara Therapeutics Inc. | Chief Medical Officer | Sale+OE10b5-1 | 11,000 | $18.65 | $205,108.20 | -23.7% | -11.2% | - | |
| Oct 9, 2025 | BCAX Bicara Therapeutics Inc. | Chief Medical Officer | Sale+OE10b5-1 | 22,000 | $18.45 | $405,900.00 | -38.3% | -6.0% | -4.2% |